KFF Health News’ ‘What the Health?’: Trump’s ‘One Big Beautiful Bill’ Lands in Senate. Our 400th Episode!

The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…

Read More

Its Own Reward: NEMT Services Meet Challenge for Special Needs Patients

NEMT providers play a key role, providing lifelines by delivering the crucial connection between patients and the care they need. This responsibility becomes even more critical when serving individuals with special needs, such as those with physical disabilities, behavioral health conditions, developmental delays or age-related limitations. The post Its Own Reward: NEMT Services Meet Challenge…

Read More

Inside Providence’s Health Equity & Medicaid Strategy

Whitney Haggerson — vice president of health equity and Medicaid at Providence — discussed the significance of her role, as well as how her health system is working to give all employees, regardless of title, the skills needed to help reduce health inequities. The post Inside Providence’s Health Equity & Medicaid Strategy appeared first on…

Read More

With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis

Arrowhead Pharmaceuticals’ RNAi drug plozasiran, brand name Redemplo, is now the second FDA-approved therapy for familial chylomicronemia syndrome, an inherited lipid disorder. Beyond its claims of safety and dosing advantages, Arrowhead set a dramatically lower price for its first commercial product, which will compete against an Ionis Pharmaceuticals drug. The post With FDA Approval for…

Read More